Correlation Between Impinj and Regeneron Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Impinj and Regeneron Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Impinj and Regeneron Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Impinj Inc and Regeneron Pharmaceuticals, you can compare the effects of market volatilities on Impinj and Regeneron Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Impinj with a short position of Regeneron Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Impinj and Regeneron Pharmaceuticals.

Diversification Opportunities for Impinj and Regeneron Pharmaceuticals

  Correlation Coefficient

Weak diversification

The 3 months correlation between Impinj and Regeneron is 0.39. Overlapping area represents the amount of risk that can be diversified away by holding Impinj Inc and Regeneron Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Regeneron Pharmaceuticals and Impinj is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Impinj Inc are associated (or correlated) with Regeneron Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Regeneron Pharmaceuticals has no effect on the direction of Impinj i.e., Impinj and Regeneron Pharmaceuticals go up and down completely randomly.

Pair Corralation between Impinj and Regeneron Pharmaceuticals

Allowing for the 90-day total investment horizon Impinj Inc is expected to generate 2.88 times more return on investment than Regeneron Pharmaceuticals. However, Impinj is 2.88 times more volatile than Regeneron Pharmaceuticals. It trades about 0.12 of its potential returns per unit of risk. Regeneron Pharmaceuticals is currently generating about 0.03 per unit of risk. If you would invest  11,332  in Impinj Inc on September 2, 2022 and sell it today you would earn a total of  897.50  from holding Impinj Inc or generate 7.92% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
ValuesDaily Returns

Impinj Inc  vs.  Regeneron Pharmaceuticals

 Performance (%) 
Impinj Inc 
Impinj Performance
10 of 100
Compared to the overall equity markets, risk-adjusted returns on investments in Impinj Inc are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite nearly conflicting forward indicators, Impinj reported solid returns over the last few months and may actually be approaching a breakup point.

Impinj Price Channel

Regeneron Pharmaceuticals 
Regeneron Performance
11 of 100
Compared to the overall equity markets, risk-adjusted returns on investments in Regeneron Pharmaceuticals are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Despite quite uncertain technical and fundamental indicators, Regeneron Pharmaceuticals disclosed solid returns over the last few months and may actually be approaching a breakup point.

Regeneron Price Channel

Impinj and Regeneron Pharmaceuticals Volatility Contrast

   Predicted Return Density   

Pair Trading with Impinj and Regeneron Pharmaceuticals

The main advantage of trading using opposite Impinj and Regeneron Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Impinj position performs unexpectedly, Regeneron Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Regeneron Pharmaceuticals will offset losses from the drop in Regeneron Pharmaceuticals' long position.
Impinj vs. Coca-Cola Co
The idea behind Impinj Inc and Regeneron Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Regeneron Pharmaceuticals vs. Walmart
Regeneron Pharmaceuticals vs. Meta Materials
Regeneron Pharmaceuticals vs. Dupont De Nemours
Regeneron Pharmaceuticals vs. Verizon Communications
Check out your portfolio center. Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Analyst Recommendations module to analyst recommendations and target price estimates broken down by several categories.

Other Complementary Tools

Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
ETF Directory
Find actively traded Exchange Traded Funds (ETF) from around the world
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories